Targeted delivery aids in minimizing most of the drug-originated systemic toxic effects as well as improving the pharmacokinetic properties of anticancer therapeutics. Tumor targeting using hyaluronic acid (HA) as the targeting ligand has attracted a great deal of interest among a host of strategies developed to target the overexpressed tumor specific receptors. HA is an endogenous molecule that possesses a lot of biological functions in the human body. The role of HA synthases, HA degrading enzymes and the interaction of HA with its primary receptor CD44 in tumor metastasis and angiogenesis is really complex and controversial to date. However, overexpression of CD44receptors on tumor surface has been well studied, which have been utilized to direct tumor targeted drugs. Most of the HA based targeting systems were HA drug conjugates and surface modified colloidal carriers which required covalent modification. The lack of accurate structural characterization of these systems resulted in modification of HA binding sites that could affect the efficient cellular uptake. LbL technique is a simple and facile method to incorporate several materials into polyelectrolyte assemblies for drug delivery applications. HA being a negatively charged polysaccharide can be easily incorporated into such systems without any covalent modification. Although HA based polyelectrolyte multilayer films and microcapsules have been reported in combination with polycations like PAH, PLL and chitosan, their application as targeted drug delivery systems have not yet been explored. Herein, two LbL architectures with HA as the terminal layer have been investigated as targeted drug carriers, which can recognize overexpressed CD44 receptors in metastatic breast cancer cells. In the first part of the thesis, a novel polyelectrolyte nanocapsule system composed of biopolymers HA and protamine sulphate (PR) as the wall components was prepared and characterized. These pH and enzyme responsive nanocapsules were then utilized for efficient loading and release of anticancer drug doxorubicin (dox). Higher drug release was observed in simulated intracellular conditions like acidic pH and presence of hyaluronidase enzyme as compared to physiological pH. In the second part of the thesis, dox incorporated bovine serum albumin (BSA) nanoparticles modified with HA-Poly(l-Lysine) multilayers were developed and characterized. The drug release pattern of the dox loaded BSA nanoparticles was found to depend on the presence of a protease enzyme trypsin than pH variations. Both of these drug delivery systems were then evaluated for their cell targeting efficiency and cytotoxicity in CD44+ positive metastatic breast cancer cell line MDA MB 231. The final layer HA facilitated targeted delivery of these drug carriers via CD44 receptor mediated endocytosis. The enhanced cellular uptake followed by sustained delivery of dox by virtue of slow intracellular enzymatic degradation of the drug carriers resulted in their improved cytotoxicity as compared to free dox. Further in vitro biodistribution and tumor suppression efficiency of both the systems were studied in breast cancer xenograft models using BALB/c nude mice. Enhance accumulation of dox in the tumor tissue and significant tumor reduction were observed when treated with encapsulated dox using the HA based nanocarriers as opposed to free dox.

Made available in DSpace on 2016-07-01T11:59:28Z (GMT). No. of bitstreams: 2 license.txt: 1748 bytes, checksum: 8a4605be74aa9ea9d79846c1fba20a33 (MD5) 4.pdf: 2145558 bytes, checksum: 50549f6c199193ece4951dbb22851f56 (MD5) Previous issue date: 2015 / Made available in DSpace on 2016-07-21T14:39:34Z (GMT). No. of bitstreams: 2 4.pdf: 2145558 bytes, checksum: 50549f6c199193ece4951dbb22851f56 (MD5) license.txt: 1748 bytes, checksum: 8a4605be74aa9ea9d79846c1fba20a33 (MD5) Previous issue date: 2015 / Fundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos/Farmanguinhos. Rio de Janeiro, RJ, Brasil. / Os sistemas de liberação transdérmica (SLT) representam atualmente uma via alternativa para a administração de fármacos por difusão passiva através da pele. Os SLT são capazes de contornar inconvenientes, como interações com alimentos e metabolismo de primeira passagem, e de substituir esquemas de doses repetidas, aumentando a adesão do paciente ao tratamento. Entretanto, não há pela Agência Nacional de Vigilância Sanitária (ANVISA) uma regulamentação específica que oriente quanto a exigências para pesquisa, desenvolvimento e registro desses medicamentos, contemplando ensaios e parâmetros definidos na avaliação de segurança e eficácia desses dispositivos. Sendo assim, esta dissertação objetiva realizar um levantamento e comparar as exigências regulatórias utilizadas para obtenção de registro dos SLT nas três principais agências, European Medicines Agency (EMA), Food and Drug Administration (FDA) e ANVISA. Adicionalmente, objetiva realizar uma análise das técnicas que vêm sendo mais vastamente empregadas nos ensaios in vitro de permeação pela comunidade científica, podendo nortear a proposta de uma metodologia harmonizada, inexistente até o momento. A definição dos parâmetros empregados na realização de tais testes é fundamental para o aumento na confiabilidade do método e simulação de biodisponibilidade in vitro, como alternativa aos testes in vivo. A partir do resultado obtido com a pesquisa concernente aos aspectos regulatórios, foi possível identificar duas diretrizes do EMA, dois guias do FDA e testes específicos para os SLT descritos na USP, como fontes suficientes na construção de uma legislação específica voltada a esses dispositivos. Com relação aos testes in vitro de permeação, dois guias da Organização para Cooperação Econômica e Desenvolvimento (OECD) e a análise da prática científica nesses ensaios, possibilitaram a realização de uma proposta para a definição dos parâmetros a serem empregados. / The transdermal drug delivery systems (TDDS) current presents an alternative for drug administration by passive diffusion throughout the skin. The TDDS are capable to avoid inconvenients, as food interactions and first pass metabolism, and to replace repetitive dose scheme, increasing patients adhesion on treatment. However, there is no specific regulation by Agência Nacional de Vigilância Sanitária (ANVISA) to guide for requirements regarding research, development and registration for this drugs, including assay and defined parameters on evaluation of safety and efficacy of these devices. So, the main objective of this work is to identify and to compare the regulatory requirements for TDDS regulatory approval of three most important agencies, European Medicines Agency (EMA), Food and Drug Administration (FDA) and ANVISA. In addition, this work aims to study the must employed techniques on in vitro permeation tests by scientific community to guide the development of an harmonized methodology, which does not exist until now. The parameters definition to be applied on these tests are essential to increase method reliability of in vitro bioavailability simulation, as an alternative for in vivo tests. With results obtained after searching about regulatory aspects, it was possible to identify two EMA guidelines, two FDA guides and specific tests related to TDDS on USP, as suficient sources for specific regulation construction focused on these devices. About in vitro permeation tests, two OECD (Organization for Economic Co-operation and Development) guides and the analysis of scientific practice on these tests, allowed a proposal definition for parameters to be employed.

Cancer is responsible for upward of 13% of human deaths. Contemporary chemotherapy of disseminated cancer is often thwarted by dose limiting systemic toxicity and by multi-drug resistance (MDR). Riminophenazines are a novel class of potential anticancer agents that possess a potent multi-mechanistic antineoplastic action. Apart from their broad action against intrinsic, non-classical resistance, Riminophenazines inhibit the action of Pgp and hypothetically all ABC transporters demonstrating their great utility against classical MDR. Considering that combination chemotherapy is the norm, the vision directing R&D efforts was that Riminophenazines could be used with benefit within many standard chemotherapeutic regimes. The strategic intent of this project was to attain improved therapeutic benefit for patients through gains in both pharmaco dynamic and pharmacokinetic specificity for cancer cells over what is currently available. Tactically, this was driven through the use of synergistic Fixed-Ratio Drug Combinations (FRDC) encapsulated within tumour-targeting Nanoparticulate Drug Delivery Systems (NDDS). Long-term aims of this R&D project were to: 1) Screen FRDC of clofazimine (B663) and the lead derivative (B4125) with etoposide, paclitaxel and vinblastine for synergistic drug interactions in vitro. 2) Design, assemble and characterize a novel nanoparticulate, synergistic, anticancer co-formulation. 3) Evaluate the in vivo safety and efficacy of the developed product/s in accordance with international regulatory guidelines. Using the median effect and combination index equations, impressive in vitro synergistic drug interactions (CI<1) were shown for various FRDC of the three standard chemotherapeutics tested (etoposide, paclitaxel and vinblastine) in combination with either B663 or B4125 against MDR neoplastic cell cultures. Considering in vitro results and with the view to advance quickly to clinical studies, the already approved clofazimine (B663) was elected as the combination partner for paclitaxel (PTX). Considering the potency and wide action of PTX, a novel coformulation (designed to circumvent drug resistance) has the potential to greatly impact upon virtually all cancer types, particularly if selectively delivered through innovative delivery systems and loco-regional administration. A passively tumour targeting, micellular NDDS system called Riminocelles™ that encapsulates a synergistic FRDC of B663 and PTX has been designed, assembled using thin film hydration methods and characterized in terms of drug loading, particle size, zeta potential, CMC and drug retention under sink conditions. An acute toxicity and a GLP repeat dose toxicity study confirmed Riminocelles to be well tolerated and safe at clinically relevant dosages whilst Taxol® (QDx7) produced statistically significant (P<0.05) weight loss within 14 days. The same study demonstrated statistically significant (P<0.05) tumour growth delays superior to that of Taxol at an equivalent PTX dosage of 10 mg/kg. Importantly, all components (amphiphiles and drugs) used in assembly of Riminocelles are already individually approved for medicinal use - this promotes accelerated development towards advanced clinical trials and successful registration. Although these results are very promising (outperforming Taxol), this system was however found in a pharmacokinetic study to suffer from in vivo thermodynamic instability due to the high concentration (abundance) of albumin present in plasma. For this reason, in vivo longevity within circulation, permitting passive tumour accumulation was not fully realized. A second NDDS called the RiminoPLUS™ imaging system was additionally developed. This lipopolymeric nanoemulsion system has successfully entrapped Lipiodol® Ultra fluid (an oil based contrast agent) within the hydrophobic core of a monodisperse particle population with a size of roughly 100 nm and a stability of one week. This formulation is therefore thought capable of CT imaging of tumour tissue and drug targeting after either intravenous or loco-regional injection. In vivo proof of the imaging concept is warranted. The results of this study serve to highlight the great potential of in vitro optimized synergistic FRDC against drug resistant cancers. Lipopolymeric micelles are an effective way to formulate multiple hydrophobic drugs for intravenous administration and present a means by which cancer can be readily targeted; provided that the delivery system possess the prerequisite in vivo stability and surface attributes. Further experiments exploring synergistic drug and biological combinations as well as “intelligent” NDDS actively guided through specific molecular recognition are called for. / Thesis (PhD)--University of Pretoria, 2012. / Pharmacology / unrestricted

In this dissertation, the roles of endocytosis and phagocytosis pathways in a variety of clinically relevant scenarios were examined. These scenarios include antibody-mediated internalization of cell surface proteins, titanium wear-particle uptake in failed joint replacements, and polymeric microparticle uptake and immune responses for drug delivery or adjuvant use. The use of antibodies specific for cell surface proteins has become a popular method to deliver therapeutics to target cells. As such, it is imperative to fully understand the ability of antibodies to mediate internalization and endosomal trafficking of the surface protein that it recognizes, so that drug delivery can be optimized. By comparing the internalization and endosomal localization of two different antibody-bound proteins, the transferrin receptor (TfR) and rabies G, we have found that there is a specific antibody-mediated internalization pathway that occurs when an antibody binds to a cell surface protein. Interestingly, the internalization pathway induced by antibody binding is different than that seen with recycling receptor internalization after ligand binding. This may have broad implications for the future development of antibody-based therapeutics. Joint replacement failure is a major clinical problem. Studies have indicated that a large amount of metal and polyethylene wear debris is found in the synovial membrane and tissue surrounding failed replacements. Through examination of the immune response following uptake of titanium particles, our results suggest that titanium wear-particle induced inflammation and subsequent joint replacement failure may be due to activation of the NLRP3 inflammasome, leading to increased IL-1ß secretion and IL-1 associated signaling. These findings introduce IL-1 as a target for potential therapeutics for patients exhibiting significant inflammation. Polymeric microparticles have been widely used in a variety of therapeutic applications, including drug delivery and vaccine adjuvants. It is essential to understand the ability of such particles to either activate or inhibit an immune response following uptake. Through comparison of particles with varying surface morphology, we have determined that particles with regions of high surface curvature (budding) are more immunogenic than particles with low surface curvature (spherical). Budding particles were more rapidly phagocytosed and induced higher levels of the inflammasome-associated cytokine, IL-1ß, when exposed to mouse macrophages. Additionally, budding particles induced a more rapid neutrophil response in vivo, when compared to spherical particles. These findings have broad implications for the development of future targeting vehicles for delivery of vaccines, drugs, proteins, and siRNA therapeutics.

Microtubule targeting agents (MTAs) are chemotherapeutics commonly used in the treatment of breast, ovarian, lung, and lymphoma cancers. There are two main classes of MTAs based upon their effects on microtubule stability. The two classes are the destabilizing agents, which include the drug vincristine, and the stabilizing agents, which include paclitaxel and epothilone B. These drugs are highly effective antineoplastics, but their use is often accompanied by several side effects, one of which is peripheral neuropathy. Peripheral neuropathy can be characterized by burning pain, tingling, loss of proprioception, or numbness in the hands and feet. In some patients, the MTA-induced peripheral neuropathy is debilitating and dose-limiting; however, there are no effective prevention strategies or treatment options for peripheral neuropathy as the mechanisms mediating this side effect are unknown. The goal of this work was to investigate MTA-induced effects on neuronal activity and morphology in order to elucidate the underlying mechanisms involved in the development of MTA-induced peripheral neuropathy. As an indicator of sensory neuronal activity, the basal and stimulated release of the putative nociceptive peptide, calcitonin gene-related peptide (CGRP), was measured from sensory neurons in culture after exposure to the MTAs paclitaxel, epothilone B, and vincristine. Neurite length and branching were also measured in sensory neuronal cultures after treatment with these MTAs. The results described in this thesis demonstrate that MTAs alter the stimulated release of CGRP from sensory neurons in differential ways depending on the MTA agent employed, the CGRP evoking-stimulus used, the concentration of the MTA agent, the duration of exposure to the MTA agent, and the presence of NGF. It was also observed that MTA agents decrease neurite length and branching, independent of the concentration of NGF in the culture media. Thus, this thesis describes MTA-induced alterations of sensory neuronal sensitivity and neurite morphology and begins to elucidate the underlying mechanisms involved in MTA-induced alterations of sensory neurons. These findings will undoubtedly be used to help elucidate the mechanisms underlying MTA-induced peripheral neuropathy.

No / Infection is the major reason of GTR/GBR membrane failure in clinical application. In this work, we developed GTR/GBR nanofiber membranes with localized drug delivery function to prevent infection. Metronidazole (MNA), an antibiotic, was successfully incorporated into electrospun polycaprolactone (PCL) nanofibers at different concentrations (0, 1, 5, 10, 20, 30, and 40 wt% polymer). To obtain the optimum anti-infection membrane, we systematically investigated the physical-chemical and mechanical properties of the nanofiber membranes with different drug contents. The interaction between PCL and MNA was identified by molecular dynamics simulation. MNA released in a controlled, sustained manner over 2 weeks and the antibacterial activity of the released MNA remained. The incorporation of MNA improved the hydrophilicity and in vitro biodegradation rate of PCL nanofibers. The nanofiber membranes allowed cells to adhere to and proliferate on them and showed excellent barrier function. The membrane loaded with 30% MNA had the best comprehensive properties. Analysis of subcutaneous implants demonstrated that MNA-loaded nanofibers evoked a less severe inflammatory response than pure PCL nanofibers. These results demonstrate the potential of MNA-loaded nanofiber membranes as GTR/GBR membrane with antibacterial and anti-inflammatory function for extensive biomedical applications.

Yes / Infection is the major reason for guided tissue regeneration/guided bone regeneration (GTR/GBR) membrane failure in clinical application. In this work, we developed GTR/GBR membranes with localized drug delivery function to prevent infection by electrospinning of poly(ε-caprolactone) (PCL) and gelatin blended with metronidazole (MNA). Acetic acid (HAc) was introduced to improve the miscibility of PCL and gelatin to fabricate homogeneous hybrid nanofiber membranes. The effects of the addition of HAc and the MNA content (0, 1, 5, 10, 20, 30, and 40 wt.% of polymer) on the properties of the membranes were investigated. The membranes showed good mechanical properties, appropriate biodegradation rate and barrier function. The controlled and sustained release of MNA from the membranes significantly prevented the colonization of anaerobic bacteria. Cells could adhere to and proliferate on the membranes without cytotoxicity until the MNA content reached 30%. Subcutaneous implantation in rabbits for 8 months demonstrated that MNA-loaded membranes evoked a less severe inflammatory response depending on the dose of MNA than bare membranes. The biodegradation time of the membranes was appropriate for tissue regeneration. These results indicated the potential for using MNA-loaded PCL/gelatin electrospun membranes as anti-infective GTR/GBR membranes to optimize clinical application of GTR/GBR strategies.

Les polyesters aliphatiques, comme le poly(acide malique) et ses dérivés, sont une famille de polymères aux propriétés de bio(comptabilité) et de bio(dégradabilité) remarquables, qui en font des candidats de choix pour l'élaboration de systèmes de vectorisation de principes actifs. Généralement, ces polymères sont synthétisés via des réactions de polymérisation utilisant des amorceurs, voir des catalyseurs, organiques, organométalliques ou métalliques. La présence de ces molécules, même à l'état de traces, peut être à l'origine d'une toxicité non souhaitée. Par conséquent, l'utilisation de biocatalyseurs, comme les lipases, se développe pour apporter une solution à cet inconvénient. Cependant, cette voie de synthèse enzymatique fait face à d'autres problèmes, tels qu'une polymérisation moins bien maîtrisée et des polymères de masses molaires faibles. Cette thèse a donc pour objectif de mettre au point une voie de polymérisation du malolactonate de benzyle utilisant la lipase de pancréas de porc (PPL) comme amorceur. Dans un premier temps, nous avons optimisé certains paramètres réactionnels permettant d'obtenir des poly(malate de benzyle) , PMLABe, de masses molaires suffisamment élevées pour que ces polymères puissent être utilisés dans la formulation de vecteurs de principes actifs, grâce à l'utilisation et l'extrapolation d'un plan d'expérience. Nous nous sommes ensuite intéressés à la compréhension du mécanisme réactionnel de la polymérisation enzymatique du malolactonate de benzyle, une β-lactone β-substituée. Les différentes études menées ont permis d'approfondir notre connaissance dans ce domaine. Deux mécanismes ont été proposés et des expériences sont en cours pour confirmer l'un d'entre eux. Finalement, comme l'objectif initial est de proposer une méthode de synthèse de dérivés du PMLA plus biocompatibles conduisant à des polymères sans résidus d'amorceurs chimiques toxiques, nous avons comparé les activités biologiques de nanoparticules préparées à partir de PMLABe synthétisés par voie chimique et par voie enzymatique. Pour cela, nous avons mesuré la captation de ces nanoparticules, encapsulant une sonde de fluorescence, par des cellules hépatiques HepaRG. Puis, nous avons évalué la toxicité aiguë et la toxicité chronique de ces nanoparticules vis-à-vis des cellules HepaRG. Ces études ont permis de mettre en évidence certaines propriétés des nanoparticules ayant une influence sur la survie cellulaire et le métabolisme des cellules HepaRG. De la compréhension théorique aux applications potentielles, cette thèse apporte des connaissances sur la polymérisation enzymatique des lactones substituées, un domaine peu décrit dans la littérature. / Aliphatic polyesters, like poly(malic acid)and its derivatives, are a family of polymers with outstanding properties, such as bio(degradability) and bio(compatibility). Therefore, these polyesters can be considered as excellent candidates for the design of drug carriers. These kinds of polymers are usually synthesized thanks to polymerization reactions using organic, organometallic or metallic initiators or catalysts. The presence of such molecules, even in trace amounts, can cause undesired toxicities. Therefore, the use of biocatalysts, like lipases, is attracting more and more interest and research work to circumvent this problem. However, this enzymatic polymerization method has to face to other issues, such as a lower controlled of the polymerization process and polymers with lower molar masses. Therefore, this PhD research work aimed at setting up the enzymatic polymerization of benzyl malolactonate, using porcine pancreatic lipase (PPL). Firstly, we have optimized some reactional parameters allowing to obtain poly(benzyl malate), PMLABe, with molar masses adapted to their uses for the design of drug carriers, thanks to a Design of Experiments (DoE) and its extrapolation. We were then interested by the comprehension of the enzymatic polymerization mechanism of the benzyl malolactonate. The different studies we carried out allowed us to deepen our knowledges of such enzymatic polymerization. Two non-canonical mechanisms were proposed and further experiments are in progress to confirm the one which is the more probable. Finally, because our initial goal was to propose a more biocompatible polymerization method to obtain PMLABe free of traces of chemical initiator, we compared biologic activities of different nanoparticles prepared from PMLABe synthesized using chemical or enzymatic pathway. For that, we have first measured the uptake of these nanoparticles encapsulating a fluorescent dye, by the hepatic cells HepaRG. Then, we have studied the acute and chronic toxicity of the nanoparticles on the HepaRG cells. Results of these studies have highlighted that certain properties of the nanoparticles and/or of the polymers which constituted them have an influence on the cells viability and on the cells metabolism. From the theoretical mechanism to the probable applications, this thesis brings knowledge about the enzymatic polymerization of substituted lactone, a field poorly described in the literature.

Polymer-based drug delivery systems represent one of the promising strategies for successful tumor treatment. Conjugation of a low-molecular-weight drug to a syn- thetic polymer carrier enables targeted drug delivery to tumor tissue/cells and limited systemic toxicity of the drug. The conjugates show extended circulation time, and preferentially accumulate in tumor tissue due to the Enhanced Permeability and Re- tention (EPR) effect. The EPR effect depends on a structural anomaly in tumor neovasculature, and vasodilators were shown to enhance the EPR effect via an in- crease of blood supply in the tumor. Polymer drug carriers based on water-soluble N-(2-hydroxypropyl)methacrylamide (HPMA) benefit from variable architecture, drug loading and controlled release. HPMA-based conjugates with cancerostatics have al- ready proved high anti-tumor activity, inducing complete tumor regression followed by resistance to a second tumor challenge in experimental murine models. Three HPMA-based conjugates with organic nitrates (labeled 1, 2, and 3) were pre- pared as polymer donors of nitric oxide (NO) with the aim to intensify the EPR effect, thereby enhancing accumulation of co-administered macromolecular cancerostatics in the tumor. In this study, the conjugates were non-toxic to cancer cells and did not potentiate...

R??sum?? : Les copolym??res ?? blocs sensibles aux stimuli (SR-BCPs) et leurs assemblages, tels que les micelles, les v??sicules et les hydrogels, peuvent subir des changements physiques ou chimiques en r??ponse ?? l'??volution des conditions environnementales. Pour un excellent SR-BCP, habituellement, de l??g??res modifications de l'environnement sont suffisantes pour induire des modifications relativement drastiques dans la conformation, la structure ou les propri??t??s du polym??re. Ces polym??res sont aussi appel??s polym??res stimuli-r??actifs ou polym??res intelligents et ils ont un grand potentiel d'application dans de nombreux domaines. Au cours des deux derni??res d??cennies, un int??r??t de recherche et d??veloppement particulier a ??t?? port?? sur l'exploitation des SR-BCPs pour utilisation comme syst??mes de relargage de m??dicaments. Dans de nombreux cas, les changements induits par des stimuli dans la structure ou la morphologie des assemblages de BCPs peuvent entra??ner la lib??ration de l'esp??ce encapsul??e, parfois d'une mani??re contr??lable spatialement et temporellement par le choix d'un stimulus appropri?? et en ajustant les param??tres de la m??thode de stimulation utilis??e. De fa??on g??n??rale, le fait d???avoir un certain type de groupements r??actifs ?? un stimulus donn?? dans la structure permet aux SR-BCPs de reconna??tre et r??agir ?? ce stimulus. Malgr?? les ??normes progr??s r??alis??s sur les SR-BCPs, un certain nombre de questions fondamentales restent ?? r??soudre afin de leur permettre de se trouver dans des applications pratiques. Pour y arriver, la cl?? ou le d??fi r??side dans l???am??lioration du niveau et de la complexit?? de contr??le sur les SR-BCPs ainsi que la sensibilit?? avec laquelle ces polym??res r??agissent ?? des stimuli. G??n??ralement, il est souhaitable d'obtenir une r??action rapide sous l'action d'une stimulation mod??r??e. A cette fin, il est n??cessaire d???effectuer des recherches fondamentales sur la conception rationnelle de nouveaux SR-BCPs ainsi que sur le d??veloppement de m??thodes de stimulation qui peuvent amplifier l'effet d'un stimulus. Les travaux de recherche pr??sent??s dans cette th??se s'inscrivent dans ce domaine de recherche. Plus sp??cifiquement, nous avons ??tudi?? des micelles de BCPs qui r??pondent ?? deux types de stimuli. D'une part, nous avons ??tudi?? un m??canisme d'amplification bas?? sur l???effet des ultrasons combin?? ?? la thermosensibilit?? de BCPs. D'autre part, nous avons d??velopp?? une nouvelle conception de BCPs qui permet aux micelles d?????tre d??truites soit de mani??re photochimique, soit par des r??actions d'oxydo-r??duction, tout en ayant le nombre minimum des groupes stimuli-r??actifs dans la structure du polym??re. Notre recherche a g??n??r?? de nouvelles connaissances dans ce domaine et sugg??re de nouveaux moyens sur la fa??on dont les questions de sensibilit?? et de contr??le complexe des micelles SR-BCPs peuvent ??tre abord??es, contribuant ainsi ?? l'avancement des connaissances fondamentales. Le c??ur de cette th??se est compos?? de trois publications r??sultant des projets r??alis??s. Dans le premier projet, afin de coupler la sensibilit?? aux ultrasons et la thermosensibilit??, nous avons men?? une ??tude ayant pour but de trouver des structures possibles de polym??res qui sont susceptibles d'??tre affect??es par les ultrasons. Nous avons effectu?? une ??tude comparative sur la destruction des micelles form??es par divers BCPs et la lib??ration concomitante d'un colorant hydrophobe encapsul?? (rouge du Nil) par les ultrasons focalis??s de haute intensit?? (HIFU). Nous avons constat?? que toutes les micelles form??es par les quatre copolym??res diblocs synth??tis??s, ??tant constitu??s d'un m??me bloc du polyoxyde d'??thyl??ne (PEO) hydrophile et d???un bloc de polym??thacrylate hydrophobe diff??rent, peuvent ??tre perturb??es par les ultrasons. Toutefois, l'ampleur de la perturbation et la lib??ration du colorant encapsul?? dans la micelle est influenc??e par la structure chimique du block hydrophobe. En particulier, les micelles du PEO-b-PIBMA (poly(1-isobutoxym??thacrylate d'??thyle)) et du PEO-b-PTHPMA (poly(m??thacrylate de 2-t??trahydropyrannyle)), qui poss??dent une unit?? ac??tal labile dans le groupe lat??ral, subissent des perturbations plus importantes en raison, probablement, d???une r??action d???hydrolyse de l???ester induite par les ultrasons, donnant lieu ?? une lib??ration plus rapide du colorant. En revanche, les micelles du PEO-b-PMMA (poly(m??thacrylate de m??thyle)), dont le bloc polym??thacrylate est plus stable, sont plus r??sistantes aux ultrasons et pr??sentent une cin??tique de lib??ration du colorant plus lente que les autres micelles. De plus, l???analyse des spectres infrarouges des solutions micellaires, enregistr??s avant et apr??s l???exposition aux ultrasons, sugg??re une r??action d???hydrolyses pour le PEO-b-PIBMA et le PEO-b-PTHPMA, mais montre l'absence d???une quelconque r??action chimique pour le PEO-b-PMMA. L'effet de la structure de copolym??re ?? blocs sur la r??activit?? des micelles ?? l'irradiation HIFU ?? hautes fr??quences permet de mieux comprendre comment des micelles de BCPs sensibles aux ultrasons peuvent ??tre con??ues. Sur la base du premier projet, dans le deuxi??me projet, nous avons d??montr?? une nouvelle approche pouvant amplifier l'effet de HIFU sur la destruction des micelles de BCPs en solution aqueuse. L???id??e est d???introduire une petite quantit?? des unit??s comonom??res sensibles aux ultrasons dans le bloc thermosensible et initialement hydrophobe. On peut alors former une micelle dont le noyau est compos?? du polym??re sensible aux ultrasons. Si la r??action induite par les ultrasons sur le noyau permet d???augmenter la temp??rature de solution critique inf??rieure (LCST) du polym??re thermosensible au-dessus de la temp??rature de la solution micellaire, la micelle doit ??tre dissolue car tout le BCP est devenu soluble dans l???eau. Pour tester la validit?? de ce nouveau m??canisme, nous avons synth??tis?? et ??tudi?? un copolym??re dibloc de PEO-b-P(MEO[indice inf??rieur 2]MA-co-THPMA) (MEO[indice inf??rieur 2]MA repr??sente 2-(2-m??thoxy??thoxy) m??thacrylate d'??thyle), dans lequel le bloc thermosensible P(MEO[indice inf??rieur 2]MA-co-THPMA) est hydrophobe ?? T>LCST. Le THPMA a ??t?? choisi en raison de sa plus grande r??activit?? vis-??-vis des faisceaux HIFU que les autres monom??res ??tudi??s dans le premier projet. Les r??sultats montrent que les HIFU peuvent effectivement augmenter la LCST du bloc P(MEO[indice inf??rieur 2]MA-co-THPMA) et, par cons??quent, induire la dissociation des micelles ?? une temp??rature constante de la solution. Une analyse spectrale en RMN [indice sup??rieur 13]C a fourni des preuves montrant que l'hydrolyse des groupes THPMA se produit sous l???irradiation HIFU et que la destruction des micelles provient d'une augmentation de la LCST en raison de la conversion des motifs hydrophobes THPMA en motifs acides m??thacryliques (MAA) hydrophiles. Cette m??thode de modifier la LCST par une irradiation des ultrasons est g??n??rale et peut ??tre appliqu??e aux autres groupements sensibles aux ultrasons dans la conception de ce type de SR-BCPs. Cette ??tude a ainsi d??montr?? un nouveau m??canisme d'amplification et de contr??le des micelles de BCPs via la modification induite par les ultrasons de la temp??rature de transition de phase (LCST) du bloc constituant le noyau micellaire. Le troisi??me projet pr??sent?? dans cette th??se portait sur une conception rationnelle de BCPs ayant un but pr??cis: permettre aux micelles d?????tre perturb??es par deux types de stimuli en utilisant le nombre minimal des unit??s sensibles ?? des stimuli dans la structure de BCPs. Pour ce faire, nous avons con??u et synth??tis?? un nouveau copolym??re tribloc amphiphile de type ABC, soit le poly(oxyde d'??thyl??ne) - disulfure ??? polystyrene - o-nitrobenzyle - poly(2-(dim??thylamino) ??thylm??thacrylate) (PEO-S-S-PS-ONB-PDMAEMA). Il dispose d'une liaison disulfure redox-clivable entre les blocs PEO et PS ainsi que d'un groupe o-nitrobenzyle (ONB) photoclivable ?? la jonction des blocs PS et PDMAEMA. Nous avons montr?? que ce mod??le est une strat??gie utile pour permettre aux micelles de BCPs de r??pondre soit ?? un agent r??ducteur comme le dithiothr??itol (DTT) dans une solution, soit ?? l'exposition ?? la lumi??re UV, tout en ayant le nombre minimum des groups stimuli-r??actifs dans la structure du copolym??re (deux unit??s par cha??ne). Nos investigations ont r??v??l?? que les micelles de ce copolym??re tribloc peuvent ??tre perturb??es de diff??rentes fa??ons. Lorsqu'un seul stimulus est appliqu??, l'enl??vement d'un type des cha??nes de polym??re hydrophile ?? partir de la couronne de micelles, soit le PEO par clivage par oxydo-r??duction ou le PDMAEMA par photoclivage, entra??ne un effet limit?? de d??stabilisation sur la dispersion des micelles. L'agglom??ration de quelques micelles appara??t mais la dispersion reste essentiellement stable. En revanche, en cas d'utilisation combin??e des deux stimuli qui clivent ?? la fois le PEO et le PDMAEMA, une agr??gation importante du polym??re se produit ?? la suite de l'??limination de l'amphiphilicit?? du polym??re. // Abstract : Stimuli-responsive block copolymers (SR-BCPs) and their assemblies, such as micelles, vesicles and hydrogels, can undergo physical or chemical changes in response to changing environmental conditions. For an excellent SR-BCP, usually, slight changes in the environment are sufficient to induce relatively drastic changes in either the conformation or structure or properties of the polymer. Stimuli-reactive polymers are often referred to as smart polymers and they have great application potential in many fields. Over the past two decades, particular research and development interest has been focused on exploiting SR-BCP assemblies as drug delivery systems (DDSs). In many cases, stimuli-induced changes in the structure or morphology of BCP assemblies (drug carriers) can result in the release of loaded species, sometimes in a spatially and temporally controllable manner by choosing an appropriate stimulus and adjusting the parameters of the used stimulating method. Generally speaking, by having a certain type of stimuli-reactive moieties in the structure, SR-BCP assemblies have an ability to recognize a specific stimulus and react to its presence accordingly. Despite the tremendous progress achieved on SR-BCPs, a number of fundamental issues remain to be addressed in order to enable real-life applications of these smart polymers. Of them, an increasing level and complexity of control on SR-BCPs as well as the sensitivity with which these polymers react to stimuli are key and challenging. It is highly desirable to obtain a fast reaction under the action of a modest stimulation. To this end, fundamental research is necessary on rational and creative BCP structural design as well as on development of stimulation methods that can amplify the effect of a stimulus. The research work presented in this thesis falls into this important topic. More specifically, we studied BCP micelles that are responsive to two types of stimuli. On the one hand, we investigated an amplification mechanism based on coupling the ultrasound reactivity with the thermosensitivity of BCPs. On the other hand, we developed a BCP structural design that allows micelles to be disrupted by either light or redox agents while having the minimum number of stimuli-reactive moieties in the polymer structure. Our research provided new insights into and suggested new means on how the issues of sensitivity and complex control of SR-BCP micelles can be tackled, thus contributing to the advancement of fundamental knowledge. The core of this thesis is comprised of three publications resulting from the projects realized in our research work. In order to couple the ultrasound sensitivity and thermosensitivity, in the first project, we carried out studies to find possible polymer structures that are susceptible to be affected by ultrasound. We conducted a comparative study on the disruption of the micelles formed by various BCPs and the concomitant release of an encapsulated hydrophobic dye (Nile Red) by high-intensity focused ultrasound (HIFU). It was found that all micelles formed by the four synthesized diblock copolymers, being composed of a hydrophilic poly(ethylene oxide) (PEO) block and a different polymethacrylate hydrophobic block, could be disrupted by ultrasound. However, the extent of the micellar disruption and dye release was found to be influenced by the chemical structure of the micelle-core-forming hydrophobic polymethacrylate. In particular, micelles of PEO-b-PIBMA (poly(1-(isobutoxy)ethyl methacrylate)) and PEO-b-PTHPMA (poly(2-tetrahydropyranyl methacrylate)), whose hydrophobic blocks have a labile acetal unit in the side group and are more likely to undergo ester hydrolysis, could be disrupted more severely by ultrasound, giving rise to a faster release of Nile Red. By contrast, micelles of PEO-b-PMMA (poly(methyl methacrylate)), whose polymethacrylate block is more stable, appear to be more resistant to ultrasound irradiation and exhibit a slower rate of dye release than other BCPs. Moreover, infrared spectra recorded with micelles before and after ultrasound irradiation of the aqueous solution of the micelles give evidence for the occurrence of chemical reactions, most likely hydrolysis, for PEO-b-PIBMA and PEO-b-PTHPMA, but absence of chemical reactions for PEO-b-PMMA. The effect of BCP chemical structure on the reaction of micelles to high-frequency HIFU irradiation shows the perspective of designing and developing ultrasound-sensitive BCP micelles for ultrasound-based delivery applications. On the basis of the first project, in the second project, we demonstrated a new approach that could amplify the effect of HIFU on the disassembly of BCP micelles in aqueous solution. By introducing a small amount of ultrasound-labile comonomer units into the micelle core-forming thermosensitive polymer, the ultrasound-induced reaction of the comonomer could increase the lower critical solution temperature (LCST) of the thermosensitive polymer due to a polarity change, which renders the BCP soluble in water without changing the solution temperature and, consequently, results in disassembly of BCP micelles. To prove the validity of this new mechanism, we synthesized and investigated a diblock copolymer of PEO-b-P(MEO[subscript 2]MA-co-THPMA) (MEO[subscript 2]MA stands for 2-(2-methoxyethoxy)ethyl methacrylate). In the thermosensitive random copolymer block P(MEO[subscript 2]MA-co-THPMA), which is hydrophobic at T>LCST, THPMA was chosen due to its greater reactivity under HIFU than other monomer structures investigated in the first project. We found that HIFU could indeed increase the LCST of the P(MEO[subscript 2]MA-co-THPMA) block and, as a result, dissociate the BCP micelles at a constant temperature. A [superscript 13]C NMR spectral analysis provided critical evidence that hydrolysis of the THPMA groups occurs under HIFU irradiation and the micellar disassembly originates from an increase in the LCST due to the ultrasound-induced conversion of hydrophobic comonomer units of THPMA onto hydrophilic methacrylic acid (MAA). This ultrasound-changeable-LCST approach is general and can be applied by exploring other ultrasound-labile moieties in the BCP design. By transducing an ultrasound-induced effect into a changing thermosensitivity of the micelle core-forming block, this study demonstrated a new amplification and control mechanism for SR-BCP micelles. The third project presented in this thesis dealt with a rational BCP design that had a specific purpose: allowing BCP micelles to be disrupted by two types of stimuli while using the minimum number of stimuli-reactive moieties in the BCP structure. The unveiling of such BCP structures provides insight into how to make BCP micelles sensitive to stimuli. To do this, we designed and synthesized a new amphiphilic ABC-type triblock copolymer, namely, poly(ethylene oxide)-disulfide-polystyrene- o-nitrobenzyl-poly(2-(dimethylamino)ethylmethacrylate) (PEO-S-S-PS-ONB-PDMAEMA), which features a redox-cleavable disulfide linkage between the PEO and PS blocks as well as a photocleavable ONB group as the junction of the PS and PDMAEMA blocks. We demonstrated that this design is a useful strategy to allow BCP micelles to respond to both a reducing agent like dithiothreitol (DTT) in solution and exposure to UV light while having the minimum number of stimuli-reactive moieties in the block copolymer structure (two units per chain). Our investigations found that the micelles of this triblock copolymer could be disrupted in different ways. When only one stimulus is applied, the removal of one type of hydrophilic polymer chains from the micelle corona, either PEO by redox-cleavage or PDMAEMA by photocleavage, results in a limited destabilization effect on the dispersion of the micelles. The agglomeration between a few micelles appears but the dispersion remains essentially stable. By contrast, under combined use of the two stimuli that cleaves both PEO and PDMAEMA, severe polymer aggregation occurs as a result of elimination of the polymer amphiphilicity. Moreover, by loading the hydrophobic Nile Red in the micelles, the fluorescence quenching of the dye by aqueous medium under the different uses of the two stimuli appears to correlate with the different extents of the micellar disruption. // ?????? : ??????????????????????????????SR-BCPs???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????SR-BCP???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????-??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????SR-BCP?????????????????????????????????DDSs???????????????????????????????????????BCP?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????-????????????????????????SR-BCP??????????????????????????????????????????????????????????????????????????? ??????SR-BCPs?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????SR-BCPs?????????????????????????????????????????????????????????????????????SR-BCPs???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????BCP???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????BCP???????????????????????????BCPs???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????-???????????????BCP???????????????????????????????????????????????????????????????????????????????????????SR-BCP???????????????????????????????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????BCPs????????????????????????????????????????????????HIFU?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????PEO-b-PIBMA????????? 1-????????????????????????????????????????????? ??????PEO-b-PTHPMA?????????2-???????????????????????????????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????????????????????????????????????????PEO-b-PMMA?????????????????????????????????????????????????????????????????????????????????????????????????????????PEO-b-PMMA????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????PEO-b-PIBMA???PEO-b-PTHPMA????????????????????????????????????????????????PEO-b-PMMA???????????????????????????????????????HIFU????????????BCP???????????????????????????????????????????????????????????????????????????-??????BCP????????????????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????HIFU??????????????????BCP???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????LCST?????????????????????????????????????????????????????????BCP??????????????????????????????BCP??????????????????????????????????????????????????????????????????????????????????????????????????????PEO-b-P(MEO2MA-co-THPMA) ???MEO2MA ??????2-???2-??????????????????????????????????????????????????????T > LCST????????????????????????????????????P(MEO2MA-co-THPMA)?????????????????????THPMA?????????????????????????????????????????????????????????????????????????????????HIFU?????????????????????????????????????????????????????????????????? ??????HIFU???????????????????????????P(MEO2MA-co-THPMA)?????????LCST?????????BCP??????????????????????????????????????????13C NMR ???????????????????????????THPMA?????????????????????????????????????????????THPMA??????????????????????????????MAA?????????LCST?????????????????????????????????????????????????????????????????????LCST??????????????????????????????????????????????????????BCP???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????SR-BCP????????????????????????????????? ????????????????????????????????????????????????????????????????????????????????????????????????BCP????????????????????????????????????????????????????????????????????????BCP?????????????????????????????????????????????BCP?????????????????????????????????????????????????????????BCP????????????????????????????????????????????????????????????????????????ABC???????????????????????????????????????????????? - ???????????? - ???????????? - ??? - ???????????? - ?????? 2 - ???????????????????????????????????????????????? (PEO-S-S-PS-ONB-PDMAEMA)?????????PEO???PS???????????????????????????????????????????????????PS???PDMAEMA?????????????????????????????????ONB????????????????????????????????????????????????????????????-??????????????????????????????????????????????????????BCP????????????????????????????????????????????? ???DDT????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????PEO????????????????????????PDMAEMA?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????PEO???PDMAEMA?????????????????????????????????????????????????????????????????????????????????????????????????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????